BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24200511)

  • 1. Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis.
    Gray Gilstrap L; Niehaus E; Malhotra R; Ton VK; Watts J; Seldin DC; Madsen JC; Semigran MJ
    J Heart Lung Transplant; 2014 Feb; 33(2):149-56. PubMed ID: 24200511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience.
    Grogan M; Gertz M; McCurdy A; Roeker L; Kyle R; Kushwaha S; Daly R; Dearani J; Rodeheffer R; Frantz R; Lacy M; Hayman S; McGregor C; Edwards B; Dispenzieri A
    World J Transplant; 2016 Jun; 6(2):380-8. PubMed ID: 27358783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease?
    Hsich EM; Rogers JG; McNamara DM; Taylor DO; Starling RC; Blackstone EH; Schold JD
    JACC Heart Fail; 2016 Sep; 4(9):689-97. PubMed ID: 27179836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure.
    Maurer MS; Raina A; Hesdorffer C; Bijou R; Colombo P; Deng M; Drusin R; Haythe J; Horn E; Lee SH; Marboe C; Naka Y; Schulman L; Scully B; Shapiro P; Prager K; Radhakrishnan J; Restaino S; Mancini D
    Transplantation; 2007 Mar; 83(5):539-45. PubMed ID: 17353770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and autologous stem cell transplantation hematopoietic in patients with AL amyloidosis.
    Carretero M; Villanueva E; Brulc EB; Faelo FM; Aguirre MA; Pérez-de-Arenaza D; Belziti CA; Arbelbide JA; Nucifora EM; Posadas-Martinez ML
    Arch Cardiol Mex; 2023; 93(4):435-441. PubMed ID: 37972368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
    Scully MS; Wessman DE; McKee JM; Francisco GM; Nayak KR; Kobashigawa JA
    Mil Med; 2017 Mar; 182(3):e1858-e1860. PubMed ID: 28290973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies.
    Varr BC; Liedtke M; Arai S; Lafayette RA; Schrier SL; Witteles RM
    J Heart Lung Transplant; 2012 Mar; 31(3):325-31. PubMed ID: 22051505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.
    Estep JD; Bhimaraj A; Cordero-Reyes AM; Bruckner B; Loebe M; Torre-Amione G
    Methodist Debakey Cardiovasc J; 2012; 8(3):8-16. PubMed ID: 23227279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and survival of patients with chemotherapy-induced cardiomyopathy undergoing heart transplantation.
    Oliveira GH; Hardaway BW; Kucheryavaya AY; Stehlik J; Edwards LB; Taylor DO
    J Heart Lung Transplant; 2012 Aug; 31(8):805-10. PubMed ID: 22551930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the UNOS heart transplant allocation system favor men over women?
    Hsich EM; Starling RC; Blackstone EH; Singh TP; Young JB; Gorodeski EZ; Taylor DO; Schold JD
    JACC Heart Fail; 2014 Aug; 2(4):347-55. PubMed ID: 25023811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart transplant outcomes in patients with left ventricular non-compaction cardiomyopathy.
    Al-Kindi SG; El-Amm C; Ginwalla M; Hoit BD; Park SJ; Oliveira GH
    J Heart Lung Transplant; 2015 Jun; 34(6):761-5. PubMed ID: 25572453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waitlist Mortality of Patients With Amyloid Cardiomyopathy who Are Listed for Heart Transplantation and Implications for Organ Allocation.
    Panhwar MS; Al-Kindi SG; Tofovic D; Oliveira GH; Ginwalla M
    J Card Fail; 2019 Sep; 25(9):767-771. PubMed ID: 31018167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of surveillance and clinically prompted right heart catheterization in patients listed for heart transplantation.
    Ahluwalia M; Jessup M; Forde KA; Sehgal S; Katz ST; Quiaoit YAA; Hornsby N; Owens AT; McLean RC
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):28-34. PubMed ID: 30953421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation.
    Weiss ES; Allen JG; Russell SD; Shah AS; Conte JV
    J Heart Lung Transplant; 2009 Nov; 28(11):1150-7. PubMed ID: 19782581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungle.
    Potena L; Quarta CC; Grigioni F; Rapezzi C
    J Heart Lung Transplant; 2014 Feb; 33(2):136-8. PubMed ID: 24480447
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for early death in patients bridged to transplant with continuous-flow left ventricular assist devices.
    Arnaoutakis GJ; George TJ; Kilic A; Beaty CA; Weiss ES; Conte JV; Shah AS
    Ann Thorac Surg; 2012 May; 93(5):1549-54; discussion 1555. PubMed ID: 22429670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.
    Dey BR; Chung SS; Spitzer TR; Zheng H; Macgillivray TE; Seldin DC; McAfee S; Ballen K; Attar E; Wang T; Shin J; Newton-Cheh C; Moore S; Sanchorawala V; Skinner M; Madsen JC; Semigran MJ
    Transplantation; 2010 Oct; 90(8):905-11. PubMed ID: 20733534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.
    Gillmore JD; Goodman HJ; Lachmann HJ; Offer M; Wechalekar AD; Joshi J; Pepys MB; Hawkins PN
    Blood; 2006 Feb; 107(3):1227-9. PubMed ID: 16210334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart transplantation in cardiac amyloidosis.
    Sousa M; Monohan G; Rajagopalan N; Grigorian A; Guglin M
    Heart Fail Rev; 2017 May; 22(3):317-327. PubMed ID: 28281017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.